Cancer Imaging Technology – Michelson Diagnostics Announces Development Of In-Vivo OCT Probes

Cancer imaging technology company Michelson Diagnostics Ltd (MDL) has announced that it hascommenced the engineering phase of its development of probes for in-vivo imaging with opticalcoherence tomography (OCT).According to MDL Applications Director Dr Gordon McKenzie, more than one type of probe will startclinical testing during 2008.